Study | Site | Number of patients | Average follow-up (months) | Type of tumor | Type of reconstruction | Reconstruction survival | MSTS functional score | Infection rate | Nonunion rate |
---|---|---|---|---|---|---|---|---|---|
Current series | Around knee | 8 | 54 | GCT | Autograft-prosthesis composite | 100% | 88% | 0 | 0 |
Song (2012) [20] | Proximal tibia | 25 | >10 years | Malignant tumors | Pasteurized autograft-prosthesis composite | 68.7% | 83.6% | 20% | NA |
Gilbert (2009) [13] | Proximal tibia | 12 | 49 | NA | Allograft-prosthesis composite | NA | 81% | 8.3% | 25% |
Donati (2008) [15] | Proximal tibia | 62 | 72 | 56 malignant tumors | Allograft-prosthesis composite | 73% | 90.4% | 24.2% | 12.9% |
4 GCT | |||||||||
2 failure operation | |||||||||
Jeon (2007) [19] | Distal femur | 15 | 56 | Osteosarcoma | Pasteurized autograft-prosthesis composite | 100% | 86% | 0 | 33% |
Biau (2007) [14] | Proximal tibia | 26 | 128 | NA | Irradiated allograft-prosthesis composite | 79.4% | NA | 23% | 73% |
Wunder (2001) [16] | Around knee | 6 | NA | Bone sarcoma | Irradiated allograft-prosthesis composite | 50% | 67% | 18% | 50% |